Insulin pump therapy in moslem patients with type 1 diabetes during ramadan fasting: An observational report

Diabetes Technology and Therapeutics

Volumn 12, Issue 4, 2010, Pages 287-290

  Benbarka, Mahmoud M ^a   Khalil, Ali B ^a   Beshyah, Salem A ^a   Marjei, Suhad ^a   Awad, Samar Abu ^a  

^a SHEIKH KHALIFA MEDICAL CITY   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; FRUCTOSAMINE; INSULIN;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DISEASE DURATION; DRUG DOSE REDUCTION; EMERGENCY CARE; FEMALE; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MAJOR CLINICAL STUDY; MALE; MOSLEM; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TREATMENT DURATION;

ADOLESCENT; ADULT; DIABETES MELLITUS, TYPE 1; FASTING; FEASIBILITY STUDIES; FEMALE; HOLIDAYS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; ISLAM; MALE; YOUNG ADULT;

EID: 77949399421     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2009.0130     Document Type: Article

References (23)

1. The Holy Quran, Sura 2:183-185
2. Beshyah SA: Fasting Ramadan for people with diabetes: medicine and fiqh united at last. Ibnosina J Med Biomed Sci 2009;1:9
3. Sulimani RA: Ramadan fasting: medical aspects in health and in disease. Ann Saudi Med 1991;11:637-641
4. Beshyah SA, Sherif I: Diabetes during Ramadan and Haj. In: Lakhdar AA, Gill GV, eds. Diabetes in the Arab World. Cambridge, UK: FSG Communications Ltd., 2005:225-240
5. Benaji B, Mounib N, Roky R, Aadil N, Houti IE, Moussamih S, Maliki S, Gressier B, El Ghomari H: Diabetes and Ramadan: review of the literature. Diabetes Res Clin Pract 2006; 73:117-125
6. Salti I, Bénard E, Detournay B, Bianchi-Biscay M, Le Brigand C, Voinet C, Jabbar A; EPIDIAR Study Group: A populationbased study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422=2001 (EPIDIAR) study. Diabetes Care 2004;27:2306-2311
7. Beshyah SA, Benbarka MM, Sherif I: Practical management of diabetes during Ramadan fast. Libyan J Med 2008;2:C185-C189
8. Mojaddidi M, Hassanein M, Malik RA: Ramadan and diabetes: evidence-based guidelines. Prescriber 2006;17:38-43
9. Diabetes and Ramadan Advisory Board: International medical recommendations for Muslim subjects with diabetes mellitus who fast during the month of Ramadan. Clin Diabetes (Middle East Ed) 2004;3:143-145
10. Al-Arouj M, Bouguerra R, Buse J, Hafez S, Hassanein M, Ibrahim MA, Ismail-Beigi F, El-Kebbi I, Khatib O, Kishawi S, Al-Madani A, Mishal AA, Al-Maskari M, Nakhi AB, Al- Rubean K: Recommendations for management of diabetes during Ramadan. Diabetes Care 2005;28:2305-2311
11. Shaikh S, James D, Morrissey J, Patel V: Diabetes care and Ramadan: to fast or not to fast? Br J Diabetes Vascular Dis 2001;1:65-67
12. Merheb M, Chaiban J, Salti I, Sammak I, Choucair M, Nasrallah M: Insulin pump therapy in type 1 diabetic patients: experience at the American University of Beirut Medical Center. Int J Diabetes Metab 2008;16:57-61
13. Bin-Abbas BS, Sakati NA, Raef H, Al-Ashwal AA: Continuous subcutaneous insulin infusion in type 1 diabetic Saudi children. A comparison with conventional insulin therapy. Saudi Med J 2005;26:918-922
14. Bin-Abbas BS: Insulin pump therapy during Ramadan fasting in type 1 diabetic adolescents. Ann Saudi Med 2008;28: 305-306
15. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-986
16. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial=Epidemiology of Diabetes Interventions and Complications Research Group.
17. Erratum in: N Engl J Med 2000 4;342:1376.
18. Pickup J, Keen H: Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 2002;25:593-598
19. Pickup J, Mattock M, Kerry S: Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials. BMJ 2002; 324:705
20. Pickup JC: Long-term use of continuous subcutaneous insulin infusion. Diabetes Res Clin Pract 2006;74(Suppl 2): S101-S103
21. Phillip M, Battelino T, Rodriguez H, Danne T, Kaufman F; European Society for Paediatric Endocrinology; Lawson Wilkins Pediatric Endocrine Society; International Society for Pediatric and Adolescent Diabetes; American Diabetes Association; European Association for the Study of Diabetes: Use of insulin pump therapy in the pediatric age-group: consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2007;30:1653-1662
22. National Institute for Health and Clinical Excellence: Continuous Subcutaneous Insulin Infusion for the Treatment of Diabetes Mellitus (Review of Technology Appraisal Guidance 57). July 2008 http:==www.nice.org.uk (accessed June 16, 2009)
23. Lessan NG, Abdullah A, AlMousavi H, Nasir Q, Athamneh S: Utility of continuous glucose monitoring (CGMS) to explore glycemic patterns in patients with diabetes mellitus in the UAE [abstract]. Endocr Abstracts 2006;11:P324